Mel Sorensen, President and CEO at Galera Therapeutics, Inc. (GRTX), sold 70,000 shares at $0.02 ($1K) on 2025-11-20, disclosed to the SEC on 2025-11-24.
Open-market sale of $1k GRTX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |